Journal of Cancer Research and Immuno Oncology was entering into its 5th anniversary


Journal of Cancer Research and Immuno-Oncology was completed 4 long years of publishing and was entering into its 5th year. On this occasion journal wants to thank its editorial team and authors who had contributed for the journal in the past 4 years.


Journal of Cancer Research and Immuno-Oncology has formed its editorial board with more than 10 well esteemed professionals as editors. Journal wants to thank its editorial board for the esteemed professionals in its editorial board and also the editor-in-chiefs.


It was 4 long years the journal is running successfully in the field of oncology with the help and co-operation of the editors and authors along with reviewers. The contribution of the editorial board towards the journal helped the journal to reach this integrity. Along with editors the reviewers also played a major role in the qualitative review process of the journal.


Journal of Cancer Research and Immuno-Oncology aims to publish high level research and the novel findings only after the peer review process done by the editors and high qualified reviewers. Journal also aims to promote and disseminate the case reports of the patients with cancer and Immunology related problems, review articles, mini reviews, short commentaries, letter to editors, opinion articles etc.


As our Journal belongs to open access publication, it is easily accessible to every individual so that the article can be helpful to educate more no. of people. Our journal is having more readerships from more than 50 countries all over the globe so that articles may get cited more times which increases the quality of article. Journal of Cancer Research and Immuno-Oncology follows a progressive editorial policy that encourages researchers to submit the original research, reviews and editorial observations as articles, well supported by tables and graphic representation.

How we work:

  • After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
  • A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
  • Manuscript will be published within 7days of acceptance.

Benefits on Publication:

  • Blind, peer review process with fast track publication.
  • Indexing in services such in RefSeek,Hamdard University, EBSCO A-Z,OCLC- WorldCat, Publons with an impact factor 0.38.
  • Our successful collaboration with a number of society partners will facilitates international dissemination of your articles to academicians, researchers and all scientific professionals

Maegan Smith

Managing Editor

Journal of Cancer Research and Immuno-Oncology

Whatsapp No:  +1-504-608-2390

Mail ID: